Temat: "Anti-HIV Agents" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: The association between HIV pretreatment drug resistance and virological outcomes in children and adults in sub-Saharan Africa: A systematic review and meta-analysis.
Autorzy:: Takem EN; Centers for Disease Control and Prevention (CDC), Cameroon.
Coox C; Centers for Disease Control and Prevention (CDC), Cameroon.
Shang J; Centers for Disease Control and Prevention (CDC), Cameroon.
Ndongmo C; Centers for Disease Control and Prevention (CDC), Cameroon.
Dokubo EK; Centers for Disease Control and Prevention (CDC), Cameroon.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Apr 16; Vol. 19 (4), pp. e0300456. Date of Electronic Publication: 2024 Apr 16 (Print Publication: 2024).
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:: Anti-HIV Agents*/pharmacology
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV-1*
Adult ; Child ; Humans ; Anti-Retroviral Agents/therapeutic use ; Africa South of the Sahara/epidemiology ; Drug Resistance, Viral ; Viral Load

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Effects of the COVID-19 pandemic on HIV service delivery and viral suppression: Findings from the SHARP program in Northern Nigeria.
Autorzy:: Mugo C; Kenyatta National Hospital, Nairobi, Kenya.
Adedokun O; Center for International Health, Education, and Biosecurity (CIHEB), Maryland Global Initiatives Corporation (MGIC) - University of Maryland, Abuja, Nigeria.
Alo OD; Center for International Health, Education, and Biosecurity (CIHEB), Maryland Global Initiatives Corporation (MGIC) - University of Maryland, Abuja, Nigeria.
Ezeokafor N; Center for International Health, Education, and Biosecurity (CIHEB), Maryland Global Initiatives Corporation (MGIC) - University of Maryland, Abuja, Nigeria.
Adeyemi S; Chemonics International, Abuja, Nigeria.
Kpamor Z; Chemonics International, Abuja, Nigeria.
Madueke L; Chemonics International, Abuja, Nigeria.
James E; United States Agency for International Development, Abuja, Nigeria.
Adebajo SB; Center for International Health, Education, and Biosecurity (CIHEB), Maryland Global Initiatives Corporation (MGIC) - University of Maryland, Abuja, Nigeria.
Semo BW; Chemonics International, Washington, D.C., United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Apr 02; Vol. 19 (4), pp. e0300335. Date of Electronic Publication: 2024 Apr 02 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: COVID-19*/epidemiology
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Anti-HIV Agents*/therapeutic use
Anti-HIV Agents*/pharmacology
Adult ; Adolescent ; Humans ; Female ; Child ; Male ; Pandemics ; Retrospective Studies ; Nigeria/epidemiology ; Cross-Sectional Studies ; Viral Load

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: HIV protease resistance mutations in patients receiving second-line antiretroviral therapy in Libreville, Gabon.
Autorzy:: Nzengui-Nzengui GF; Département de Bactériologie- Virologie, Laboratoire National de Référence IST/VIH/Sida, Université des Sciences de la Santé, Libreville, Gabon.
Mourembou G; Département de Bactériologie- Virologie, Laboratoire National de Référence IST/VIH/Sida, Université des Sciences de la Santé, Libreville, Gabon.
M'boyis-Kamdem H; Département de Bactériologie- Virologie, Laboratoire National de Référence IST/VIH/Sida, Université des Sciences de la Santé, Libreville, Gabon.
Kombila-Koumavor AC; Département de Bactériologie- Virologie, Laboratoire National de Référence IST/VIH/Sida, Université des Sciences de la Santé, Libreville, Gabon.
Ndjoyi-Mbiguino A; Département de Bactériologie- Virologie, Laboratoire National de Référence IST/VIH/Sida, Université des Sciences de la Santé, Libreville, Gabon. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Mar 14; Vol. 24 (1), pp. 316. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:: Journal Article
MeSH Terms:: Anti-HIV Agents*/therapeutic use
Anti-HIV Agents*/pharmacology
HIV Infections*/drug therapy
HIV-1*/genetics
Male ; Humans ; Female ; Reverse Transcriptase Inhibitors/therapeutic use ; HIV Protease/genetics ; Gabon ; Anti-Retroviral Agents/therapeutic use ; Protease Inhibitors/therapeutic use ; Mutation ; Drug Resistance, Viral/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: HIV-1 Drug Resistance Detected by Next-Generation Sequencing among ART-Naïve Individuals: A Systematic Review and Meta-Analysis.
Autorzy:: Ouyang F; Key Laboratory of Environmental Medicine Engineering of Ministry of Education, Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing 210009, China.
Yuan D; Key Laboratory of Environmental Medicine Engineering of Ministry of Education, Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing 210009, China.
Zhai W; Key Laboratory of Environmental Medicine Engineering of Ministry of Education, Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing 210009, China.
Liu S; Key Laboratory of Environmental Medicine Engineering of Ministry of Education, Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing 210009, China.
Zhou Y; Department of HIV/STD Control and Prevention, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
Yang H; Key Laboratory of Environmental Medicine Engineering of Ministry of Education, Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing 210009, China.; Jiangsu Health Development Research Center, Nanjing 210029, China.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Feb 02; Vol. 16 (2). Date of Electronic Publication: 2024 Feb 02.
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:: HIV-1*/genetics
Anti-HIV Agents*/pharmacology
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV Seropositivity*
Humans ; Genotype ; Drug Resistance, Viral/genetics ; High-Throughput Nucleotide Sequencing/methods ; Prevalence ; Mutation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Analysis of ART effects and drug resistance in adult HIV/AIDS patients in Meigu County, Liangshan Prefecture, China.
Autorzy:: Yuan L; Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
Chen K; Meigu County People's Hospital, Meigu, Liangshan Prefecture, Sichuan, China.
Cai Y; Meigu County People's Hospital, Meigu, Liangshan Prefecture, Sichuan, China.
Zhou Z; Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
Yang J; Meigu County People's Hospital, Meigu, Liangshan Prefecture, Sichuan, China.
Jiqu W; Meigu County People's Hospital, Meigu, Liangshan Prefecture, Sichuan, China.
Zhu Q; Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
Zhang H; Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
Niu S; Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
Sun H; Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Feb 01; Vol. 24 (1), pp. 155. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:: Journal Article
MeSH Terms:: Acquired Immunodeficiency Syndrome*/drug therapy
Anti-HIV Agents*/pharmacology
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV-1*/genetics
Nucleic Acids*
Adult ; Humans ; Emtricitabine/therapeutic use ; Nevirapine/pharmacology ; Nevirapine/therapeutic use ; Didanosine ; Mutation ; Drug Resistance ; Drug Resistance, Viral/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: HIV viral suppression and risk of viral rebound in patients on antiretroviral therapy: a two- year retrospective cohort study in Northern Tanzania.
Autorzy:: Kahabuka MS; College of Health Sciences, Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia. .; Kibong'oto National Infectious Diseases Hospital, Kilimanjaro, Tanzania. .
Woldeamanuel Y; College of Health Sciences, Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia.
Mbelele PM; Kibong'oto National Infectious Diseases Hospital, Kilimanjaro, Tanzania.
Mpolya EA; Department of Global Health and Biomedical Sciences, School of Life Sciences and Bioengineering, Nelson Mandela African Institution of Science and Technology, Arusha, Tanzania.; Institute for Health Metrics and Evaluation, Population Health Building/Hans Rosling Center, University of Washington, 3980 15th Avenue, 98195, Seattle, WA, USA.
Mpagama SG; Kibong'oto National Infectious Diseases Hospital, Kilimanjaro, Tanzania.; Department of Global Health and Biomedical Sciences, School of Life Sciences and Bioengineering, Nelson Mandela African Institution of Science and Technology, Arusha, Tanzania.
Kessy JP; Mawenzi Regional Referral Hospital, Kilimanjaro, Tanzania.
Manyazewal T; College of Health Sciences, Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Apr 11; Vol. 24 (1), pp. 390. Date of Electronic Publication: 2024 Apr 11.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*
Acquired Immunodeficiency Syndrome*/drug therapy
Anti-HIV Agents*/therapeutic use
Humans ; Female ; Adult ; Male ; Retrospective Studies ; Antiretroviral Therapy, Highly Active ; Tanzania/epidemiology ; Viral Load

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: How men influence young women taking PrEP: perspectives from young women, male partners, and male peers in Siaya county, Western Kenya.
Autorzy:: Agot K; Impact Research and Development Organization, Mito Jura Road, off Kisumu-Kakamega Highway, Kisumu, 9171 - 40141, Kenya. .
Onyango J; Impact Research and Development Organization, Mito Jura Road, off Kisumu-Kakamega Highway, Kisumu, 9171 - 40141, Kenya.
Perry B; Department of Population Health Sciences, Duke University, Durham, NC, USA.
Molokwu N; Department of Population Health Sciences, Duke University, Durham, NC, USA.
Taylor J; Department of Population Health Sciences, Duke University, Durham, NC, USA.
Ngoje D; Impact Research and Development Organization, Mito Jura Road, off Kisumu-Kakamega Highway, Kisumu, 9171 - 40141, Kenya.
Corneli A; Department of Population Health Sciences, Duke University, Durham, NC, USA.; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.; Pokaż więcej
Źródło:: BMC women's health [BMC Womens Health] 2024 Apr 03; Vol. 24 (1), pp. 218. Date of Electronic Publication: 2024 Apr 03.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/prevention & control
HIV Infections*/drug therapy
Anti-HIV Agents*/therapeutic use
Humans ; Male ; Female ; Kenya ; Men ; Sexual Behavior

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Africa may lead rollout of long-lasting HIV drug.
Autorzy:: Cohen J; Pokaż więcej
Źródło:: Science (New York, N.Y.) [Science] 2024 Mar 29; Vol. 383 (6690), pp. 1403. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:: Wiadomości
MeSH Terms:: HIV Infections*/epidemiology
HIV Infections*/prevention & control
Anti-HIV Agents*/administration & dosage
Pre-Exposure Prophylaxis*
Humans ; Africa South of the Sahara/epidemiology ; Delayed-Action Preparations/administration & dosage ; Male ; Female ; Injections

Periodyk

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Predictors of antiretroviral treatment failure to the first line therapy: a cross-sectional study among Iranian HIV-positive adults.
Autorzy:: Hashempour A; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Khodadad N; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Ziaei R; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Rezaei B; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Ghasabi F; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Falahi S; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.; Zoonotic Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran.
Kenarkouhi A; Department of Microbiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Davarpanah MA; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran. .; Department of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Mar 28; Vol. 24 (1), pp. 358. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*
Anti-HIV Agents*
Adult ; Humans ; Iran ; Cross-Sectional Studies ; Anti-Retroviral Agents/therapeutic use ; Anti-Retroviral Agents/pharmacology ; Treatment Failure ; Viral Load ; CD4 Lymphocyte Count ; Antiretroviral Therapy, Highly Active

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Design and Synthesis of New GS-6207 Subtypes for Targeting HIV-1 Capsid Protein.
Autorzy:: Akther T; Center for Drug Design, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.
McFadden WM; Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Zhang H; Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Kirby KA; Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Sarafianos SG; Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Wang Z; Center for Drug Design, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 27; Vol. 25 (7). Date of Electronic Publication: 2024 Mar 27.
Typ publikacji:: Journal Article
MeSH Terms:: HIV-1*/genetics
Anti-HIV Agents*/pharmacology
Capsid Proteins/genetics ; Molecular Docking Simulation ; Mutation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Developing an Improved Cycle Architecture for AI-Based Generation of New Structures Aimed at Drug Discovery.
Autorzy:: Zhang C; Institute of Bioinformatics and Medical Engineering, School of Electrical and Information Engineering, Jiangsu University of Technology, Changzhou 213001, China.
Xie L; Institute of Bioinformatics and Medical Engineering, School of Electrical and Information Engineering, Jiangsu University of Technology, Changzhou 213001, China.
Lu X; Institute of Bioinformatics and Medical Engineering, School of Electrical and Information Engineering, Jiangsu University of Technology, Changzhou 213001, China.
Mao R; Institute of Bioinformatics and Medical Engineering, School of Electrical and Information Engineering, Jiangsu University of Technology, Changzhou 213001, China.
Xu L; Institute of Bioinformatics and Medical Engineering, School of Electrical and Information Engineering, Jiangsu University of Technology, Changzhou 213001, China.
Xu X; Institute of Bioinformatics and Medical Engineering, School of Electrical and Information Engineering, Jiangsu University of Technology, Changzhou 213001, China.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2024 Mar 27; Vol. 29 (7). Date of Electronic Publication: 2024 Mar 27.
Typ publikacji:: Journal Article
MeSH Terms:: Anti-HIV Agents*
Molecular Docking Simulation ; Drug Discovery ; Hydrolases ; Memory, Long-Term

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Providing medication for opioid use disorder and HIV pre-exposure prophylaxis at syringe services programs via telemedicine: a pilot study.
Autorzy:: McKellar MS; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, P.O. Box 102359, Durham, NC, 27710, USA. .
Des Marais AC; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Chen H; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Choi Y; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Lilly R; North Carolina Harm Reduction Coalition, Wilmington, NC, USA.; Port City Harm Reduction, Wilmington, NC, USA.
Ayers D; Queen City Harm Reduction, Charlotte, NC, USA.
Bennett J; North Carolina Harm Reduction Coalition, Wilmington, NC, USA.
Kestner L; Queen City Harm Reduction, Charlotte, NC, USA.
Perry B; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Poley S; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Corneli A; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, P.O. Box 102359, Durham, NC, 27710, USA.; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Meade CS; Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA.; Wake Forest University, Winston-Salem, NC, USA.
Sachdeva N; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.; North Carolina Association of County Commissioners, Raleigh, NC, USA.; Pokaż więcej
Źródło:: Harm reduction journal [Harm Reduct J] 2024 Mar 26; Vol. 21 (1), pp. 69. Date of Electronic Publication: 2024 Mar 26.
Typ publikacji:: Clinical Trial; Journal Article
MeSH Terms:: Anti-HIV Agents*/therapeutic use
HIV Infections*/prevention & control
Opioid-Related Disorders*/drug therapy
Pre-Exposure Prophylaxis*
Substance Abuse, Intravenous*/drug therapy
Humans ; Male ; Buprenorphine, Naloxone Drug Combination/therapeutic use ; Pilot Projects ; Female

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studies.
Autorzy:: Walmsley S; University Health Network, 200 Elizabeth Street, Toronto, ON, M5G 2C4, Canada.
Smith DE; Albion Centre, 150 Albion Street, Surry Hills NSW 2010, Sydney, Australia.
Górgolas M; Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Av. de los Reyes Católicos, 2, 28040, Madrid, Spain.
Cahn PE; Fundación Huésped, Dr. Carlos A. Gianantonio 3932, C1204 CABA, Buenos Aires, Argentina.
Lutz T; Infektiologikum, Stresemannallee 3, 60596, Frankfurt am Main, Frankfurt, Germany.
Lacombe K; Hôpital Saint-Antoine, 184 Rue du Faubourg Saint-Antoine, 75012, Paris, France.
Kumar PN; Georgetown University Medical Center, 4000 Reservoir Road, NW, Washington, DC, 20057, USA.
Wynne B; ViiV Healthcare, 406 Blackwell Street, Suite 300, Durham, NC, 27701, USA.
Grove R; GSK, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK.
Bontempo G; ViiV Healthcare, 36 E Industrial Road, Branford, CT, 06405, USA.
Moodley R; ViiV Healthcare, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK.
Okoli C; ViiV Healthcare, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK.
Kisare M; ViiV Healthcare, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK. .
Jones B; ViiV Healthcare, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK.
Clark A; ViiV Healthcare, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK.
Ait-Khaled M; ViiV Healthcare, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK.; Pokaż więcej
Źródło:: AIDS research and therapy [AIDS Res Ther] 2024 Mar 21; Vol. 21 (1), pp. 17. Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:: Journal Article
MeSH Terms:: HIV-1*
Anti-HIV Agents*/adverse effects
HIV Infections*/drug therapy
HIV Seropositivity*/drug therapy
Oxazines*
Piperazines*
Pyridones*
Humans ; Male ; Female ; Lamivudine/adverse effects ; Heterocyclic Compounds, 3-Ring/adverse effects ; Anti-Retroviral Agents/therapeutic use ; RNA

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Association between smoking and lack of HIV virological suppression in a cross-sectional study of persons with HIV on antiretroviral therapy in Uganda.
Autorzy:: Tumwegamire A; Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.
Fatch R; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.
Emenyonu NI; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.
Lodi S; Boston University School of Public Health, Boston, Massachusetts, United States of America.
Muyindike WR; Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.; Mbarara Regional Referral Hospital, Mbarara, Uganda.
Kekibiina A; Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.
Adong J; Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.
Ngabirano C; Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.
Beesiga B; Infectious Diseases Research Collaboration, Kampala, Uganda.
Marson K; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.
Golabi N; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.
Kamya M; Infectious Diseases Research Collaboration, Kampala, Uganda.
Chamie G; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.
Hahn JA; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Mar 20; Vol. 19 (3), pp. e0300508. Date of Electronic Publication: 2024 Mar 20 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Alcoholism*/complications
HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Anti-HIV Agents*/therapeutic use
Male ; Humans ; Adult ; Female ; Cross-Sectional Studies ; Smoking/epidemiology ; Uganda/epidemiology ; Anti-Retroviral Agents/therapeutic use ; CD4 Lymphocyte Count ; Ethanol/therapeutic use ; Viral Load

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Does HIV index testing bring patients into treatment at earlier stages of HIV disease? Results from a retrospective study in Ukraine.
Autorzy:: Secor AM; Department of Global Health, University of Washington, Hans Rosling Center, 3980 15th Ave NE, 98105, Seattle, WA, USA. .
Ihnatiuk A; International Training and Education Center for Health (I-TECH), Kyiv, Ukraine.
Shapoval A; International Training and Education Center for Health (I-TECH), Kyiv, Ukraine.
McDowell M; International Training and Education Center for Health (I-TECH), Seattle, WA, USA.
Hetman L; Public Health Center (PHC) of the Ministry of Health (MoH) of Ukraine, Kyiv, Ukraine.
Wagner AD; Department of Global Health, University of Washington, Hans Rosling Center, 3980 15th Ave NE, 98105, Seattle, WA, USA.
Pintye J; Department of Global Health, University of Washington, Hans Rosling Center, 3980 15th Ave NE, 98105, Seattle, WA, USA.
Beima-Sofie K; Department of Global Health, University of Washington, Hans Rosling Center, 3980 15th Ave NE, 98105, Seattle, WA, USA.
Golden MR; Department of Medicine, University of Washington, Seattle, WA, USA.; HIV/STD Program, Public Health-Seattle & King County, Seattle, WA, USA.
Puttkammer N; Department of Global Health, University of Washington, Hans Rosling Center, 3980 15th Ave NE, 98105, Seattle, WA, USA.; International Training and Education Center for Health (I-TECH), Seattle, WA, USA.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Mar 18; Vol. 24 (1), pp. 328. Date of Electronic Publication: 2024 Mar 18.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/diagnosis
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Anti-HIV Agents*/therapeutic use
Adult ; Humans ; Retrospective Studies ; Ukraine/epidemiology ; Anti-Retroviral Agents/therapeutic use ; HIV Testing

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Long-term HIV care outcomes under universal HIV treatment guidelines: A retrospective cohort study in 25 countries.
Autorzy:: Brazier E; City University of New York, Institute for Implementation Science in Population Health (ISPH), New York, New York, United States of America.; City University of New York, Graduate School of Public Health and Health Policy, New York, New York, United States of America.
Tymejczyk O; City University of New York, Institute for Implementation Science in Population Health (ISPH), New York, New York, United States of America.
Wools-Kaloustian K; Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
Jiamsakul A; The Kirby Institute, University of New South Wales, Sydney, Australia.
Torres MTL; Department of Pediatrics, Instituto Hondureño de Seguridad Social and Hospital Escuela Universitario, Tegucigalpa, Honduras.
Lee JS; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Abuogi L; Department of Pediatrics, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, United States of America.
Khol V; National Center for HIV/AIDS, Dermatology and STDs, Phnom Penh, Cambodia.
Mejía Cordero F; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.
Althoff KN; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Law MG; The Kirby Institute, University of New South Wales, Sydney, Australia.
Nash D; City University of New York, Institute for Implementation Science in Population Health (ISPH), New York, New York, United States of America.; City University of New York, Graduate School of Public Health and Health Policy, New York, New York, United States of America.; Pokaż więcej
Corporate Authors:: International epidemiology Databases to Evaluate AIDS (IeDEA)
Źródło:: PLoS medicine [PLoS Med] 2024 Mar 18; Vol. 21 (3), pp. e1004367. Date of Electronic Publication: 2024 Mar 18 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Adult ; Female ; Humans ; Male ; CD4 Lymphocyte Count ; Cohort Studies ; Proportional Hazards Models ; Retrospective Studies ; Observation ; Adolescent

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Factors influencing rapid antiretroviral therapy initiation in Jiulongpo, Chongqing, China: a retrospective cohort from 2018 to 2022.
Autorzy:: Chen C; Center for Disease Control and Prevention of Jiulongpo Distract, Chongqing, China.
Chen H; Center for Disease Control and Prevention of Jiulongpo Distract, Chongqing, China.
Wu L; Center for Disease Control and Prevention of Jiulongpo Distract, Chongqing, China.
Gong Q; Center for Disease Control and Prevention of Jiulongpo Distract, Chongqing, China.
He J; Center for Disease Control and Prevention of Jiulongpo Distract, Chongqing, China. .; Pokaż więcej
Źródło:: AIDS research and therapy [AIDS Res Ther] 2024 Mar 17; Vol. 21 (1), pp. 15. Date of Electronic Publication: 2024 Mar 17.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/diagnosis
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Anti-HIV Agents*/therapeutic use
Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; CD4 Lymphocyte Count ; China/epidemiology ; Proportional Hazards Models

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: "There hasn't been a push to identify patients in the emergency department"-Staff perspectives on automated identification of candidates for pre-exposure prophylaxis (PrEP): A qualitative study.
Autorzy:: Devlin SA; Department of Medicine, Section of Infectious Diseases and Global Health, University of Chicago, Chicago, Illinois, United States of America.
Johnson AK; Division of Adolescent and Young Adult Medicine, Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States of America.; Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.
Stanford KA; Department of Medicine, Section of Emergency Medicine, University of Chicago, Chicago, Illinois, United States of America.
Haider S; Department of Medicine, Section of Obstetrics and Gynecology, Rush University, Chicago, Illinois, United States of America.
Ridgway JP; Department of Medicine, Section of Infectious Diseases and Global Health, University of Chicago, Chicago, Illinois, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Mar 14; Vol. 19 (3), pp. e0300540. Date of Electronic Publication: 2024 Mar 14 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Pre-Exposure Prophylaxis*/methods
HIV Infections*/prevention & control
HIV Infections*/drug therapy
Anti-HIV Agents*/therapeutic use
Male ; Humans ; Female ; Qualitative Research ; Emergency Service, Hospital

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Acceptability and feasibility of long-term, real-time electronic adherence monitoring of HIV pre-exposure prophylaxis (PrEP) use among young women in Kenya: A mixed methods study.
Autorzy:: Ogello VA; Center of Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Rono BK; Center for microbiology research, Kenya Medical Research Institute, Kisumu, Kenya.
Ngure K; Department of Community Health, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.; Department of Global Health, University of Washington, Seattle, Washington, United States of America.
Sedah E; Center for microbiology research, Kenya Medical Research Institute, Kisumu, Kenya.
Thuo NB; Center of Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Musinguzi N; Global Health Collaborative, Mbarara, Uganda.
Baeten JM; Department of Global Health, University of Washington, Seattle, Washington, United States of America.; Gilead Sciences, Foster City, California, United States of America.
Bukusi EA; Center for microbiology research, Kenya Medical Research Institute, Kisumu, Kenya.; Department of Global Health, University of Washington, Seattle, Washington, United States of America.
Mugo NR; Center of Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.; Department of Global Health, University of Washington, Seattle, Washington, United States of America.
Haberer JE; Center for Global Health, Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Mar 07; Vol. 19 (3), pp. e0299168. Date of Electronic Publication: 2024 Mar 07 (Print Publication: 2024).
Typ publikacji:: Randomized Controlled Trial; Journal Article
MeSH Terms:: HIV Infections*/prevention & control
HIV Infections*/drug therapy
Pre-Exposure Prophylaxis*/methods
Anti-HIV Agents*/therapeutic use
Humans ; Female ; Young Adult ; Adult ; Adolescent ; Kenya ; Feasibility Studies ; Medication Adherence ; Electronics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Dolutegravir + Lamivudine vs. Dolutegravir + Tenofovir Disoproxil Fumarate/Emtricitabine: Very-Low-Level HIV-1 Replication through 144 Weeks in the GEMINI-1 and GEMINI-2 Studies.
Autorzy:: Underwood M; ViiV Healthcare, 406 Blackwell Street, Suite 300, Durham, NC 27701, USA.
Urbaityte R; GSK, 980 Great West Road, Brentford, Middlesex TW8 9GS, UK.
Wang R; ViiV Healthcare, 406 Blackwell Street, Suite 300, Durham, NC 27701, USA.
Horton J; Parexel, 2520 Meridian Parkway, Durham, NC 27713, USA.
Oyee J; GSK, 980 Great West Road, Brentford, Middlesex TW8 9GS, UK.
Wynne B; ViiV Healthcare, 406 Blackwell Street, Suite 300, Durham, NC 27701, USA.
Fox D; ViiV Healthcare, 406 Blackwell Street, Suite 300, Durham, NC 27701, USA.
Jones B; ViiV Healthcare, 980 Great West Road, Brentford, Middlesex TW8 9GS, UK.
Man C; ViiV Healthcare, 406 Blackwell Street, Suite 300, Durham, NC 27701, USA.
Sievers J; ViiV Healthcare, 980 Great West Road, Brentford, Middlesex TW8 9GS, UK.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Mar 06; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/drug therapy
Anti-HIV Agents*/therapeutic use
HIV-1*
HIV Seropositivity*
Oxazines*
Piperazines*
Pyridones*
Adult ; Humans ; Lamivudine/therapeutic use ; Emtricitabine/therapeutic use ; Tenofovir/therapeutic use ; Drug Therapy, Combination ; Heterocyclic Compounds, 3-Ring/therapeutic use ; Viral Load ; Virus Replication

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Anti-HIV Agents"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji